Blogs

    Blogs

    Tag: IO Insights

    Why SIO? Why now?
    Blog: Clinic Notes | Posted By: Michael C. Soulen | Released: February 16, 2017, 7:15 pm

    Optimal patient care is no longer the province of solitary specialists; rather it is provided by multidisciplinary care teams. This has lead to the genesis of diseased-centered subspecialty societies


    Abstract Submissions Skyrocket for WCIO 2014
    Blog: Clinic Notes | Posted By: Michael C. Soulen | Released: January 25, 2014, 1:25 pm

    I just finished reviewing my assigned batch of the hundreds of abstracts submitted to WCIO for our 10th annual scientific meeting in New York May 11-14, and what an exciting bunch they were!  The amount of innovation in the field of IO is astounding.

    2 Comment(s) — Latest:Feb 20, 2014 06:43 AM | Average Rating: 0.0/5.0 (0 ratings)
    Announcements | Help and Training | conference | Education | IO Insights | Practice development | Research | WCIO 2014

    New Years Resolutions
    Blog: Clinic Notes | Posted By: Michael C. Soulen | Released: January 12, 2014, 6:57 am

    The start of a new year is a great time to look back and forwards. WCIO made the leap from a freestanding annual scientific congress to become the world community for IO in 2010. We quickly launched IO Central, the global on-line open-membership forum for IO...


    Survival with up to 10-year Follow-up after Combination Therapy of Chemoembolization and Radiofreque
    Blog: IO Insights | Posted By: Erica Lucca | Released: June 10, 2013, 6:46 am

    Researchers in a new study sought to report 10-year outcomes of treating hepatocellular carcinomas (HCCs) by combination therapy of chemoembolization and radiofrequency (RF) ablation. Combination therapy was administered in 277 patients with 382 treatment-naïve HCCs. Therapeutic effects, safety, sur

    0 Comment(s) — Latest:None | Average Rating: 5.0/5.0 (1 ratings)
    Announcements | IO Insights

    RFA and Immunostimulant OK-432: Combination Therapy Enhances Systemic Antitumor Immunity for Treatme
    Blog: IO Insights | Posted By: Erica Lucca | Released: June 10, 2013, 6:45 am

    Researchers in Japan conducted a study to evaluate whether antitumor immunity is enhanced systemically by combining radiofrequency ablation (RFA) and local injection of an immunostimulant, OK-432. Rabbits were inoculated with VX2 tumors in the lung and the auricle were randomized into four groups of

    0 Comment(s) — Latest:None | Average Rating: 0.0/5.0 (0 ratings)
    Announcements | IO Insights


    Footer

    2025 M Street, NW, Suite 800 | Washington, DC 20036 USA
    (p) +1-202-367-1164 (f) +1-202-367-2164 (e) info@IO-central.org

    Copyright © 2017. All Rights Reserved.